Inside with Chris Bateman: When Covid-19 and chemotherapy potentially collide

Loading player...
The deadly threat of Covid-19 multiples when one's immune system is compromised, such as the three million HIV infected individuals not on ARV’s. But a double whammy is in store for those cancer patients who are undergoing chemo-therapy. Not only does chemo kill the white blood cells, whose job it is to keep our immune system working but in addition to this threat lies in the increased potential of contracting the virus. Cancer patients on chemo have no option but to make weekly trips to the hospital, a place where the severely infected need to be. How does someone on chemo right now keep themselves safe? Chris Bateman, a well-known journalist and contributor to Biznews has first hand knowledge on this. Himself a cancer victim currently undergoing chemotherapy Chris tells us how he anticipates a 12-month lockdown, and the extra measures he is taking to keep Covid-19 away from his door. - Vanessa Marks Learn more about your ad choices. Visit megaphone.fm/adchoices
28 Apr 2020 9AM English South Africa Investing · Business News

Other recent episodes

BNC#8; John Endres Q&A - Jobs, politics and the investment freeze no one wants to admit

South Africa’s future hinges on one simple truth: jobs come from growth, and growth comes from political choices. This sharp discussion unpacks how policy, ideology, and global alignment are choking investment and costing livelihoods. Inside the ANC, paralysis, fear, and patronage block reform - despite clear evidence of what works…
10 Apr 9AM 32 min

Roy Tilley: The municipal "Rates Randage Monster" strangling South Africa's property owners

Durban businessman Roy Tilley says a deeply flawed municipal rates formula is pushing property owners and small businesses toward a financial breaking point. In this interview, the Queensmead industrial property owner explains why he believes ever-rising rates are becoming impossible to absorb, hurting tenants, jobs and investment, and argues that…
10 Apr 9AM 20 min